A new Youtube channel from Lilac Corp. aims to provide information on the features and benefits of the natural antiviral formula of Gene-Eden-VIR.

ROCHESTER, NEW YORK, UNITED STATES OF AMERICA, January 5, 2016 /EINPresswire.com/ -- The Center for the Biology of Chronic Disease (CBCD) points out a new Youtube channel, which features videos designed to provide viewers with information on the features and benefits of Gene-Eden-VIR. These videos also provide accurate scientific and medical information on the latent viruses the Gene-Eden-VIR formula was designed to combat.

“In our Youtube channel, viewers will find fun, information filled videos that answer important questions about infections with viruses like herpes and HPV. We also bring viewers the most up-to-date, cutting edge research on medical treatments and remedies like Gene-Eden-VIR and Novirin. We explain everything in a way that’s easy to understand. Every week, people will find new videos that cover a wide variety of topics. For example, should an individual get tested for an HPV or Herpes infection? We’ll answer this, and many other relevant questions.” – Ashley Cohen, Video Host

The new Youtube channel can be see here:
https://www.youtube.com/channel/UCvws4vp7mvwjvN_yiyY0_QA/feed

When discussing Gene-Eden-VIR and the scientific and medical evidence that back its antiviral formula, Ms. Cohen is referring to two separate post-marketing clinical studies that followed FDA guidelines. These found that the Gene-Eden-VIR formula reduces symptoms associated with certain viruses, such as the herpes simplex virus and the human papillomavirus (HPV), among others.

Additionally, the formula of these products was designed to help boost the immune system, and target the latent form of these viruses.

The formula of Gene-Eden-VIR was tested by Hanan Polansky and Edan Itzkovitz from the CBCD. The studies showed that the Gene-Eden-VIR formula is effective against the family of herpes viruses, including HSV-1 and HSV-2 (and other viruses). The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, “individuals infected with (HSV-1 or HSV-2)…reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR.” (1) The study authors also wrote that, “we observed a statistically significant decrease in the severity, duration, and frequency of symptoms.” (1)

Gene-Eden-VIR can be ordered on its website, here:
http://www.gene-eden-vir.com

Gene-Eden-VIR is a natural antiviral dietary supplement. Its formula contains five natural ingredients: Selenium, Camellia Sinensis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses.

To date, Gene-Eden-VIR and its sister product, Novirin, are the only natural antiviral products on the market with published clinical studies that support their claims.

“We recommend that individuals concerned about infection with a latent herpes or HPV virus, take Novirin or Gene-Eden-VIR. We also recommend that people view the videos produced on the subject of Gene-Eden-VIR and latent viruses.” – Greg Bennett, CBCD

The new Youtube channel and its videos can be viewed here:
https://www.youtube.com/channel/UCvws4vp7mvwjvN_yiyY0_QA/feed

Find us on Facebook here: https://www.facebook.com/GeneEdenVIR
Follow us Twitter here: @HananPolansky

All orders of Gene-Eden-VIR and Novirin are completely confidential, and no information is shared or sold to any third party. Privacy is assured.

References:

(1) Polansky, H. Itzkovitz, E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published in September 2013.
http://www.scirp.org/journal/PaperInformation.aspx?PaperID=36101

Greg Bennett
CBCD
585-250-9999
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.